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Background/aim: The COVID-19 outbreak is known to increase stress levels of most patients with chronic diseases. Patients with
ankylosing spondylitis (AS) and rheumatoid arthritis (RA) are highly susceptible to environmental stress. In the current study, we aimed
to determine how the COVID-19 pandemic psychologically affected patients with chronic progressive diseases such as AS and RA and
the effects of these psychological factors on disease activity.
Materials and methods: Age and sex-matched patients with AS (n = 80), RA (n = 80), and healthy controls (n = 80) were included in
the study. All participants were evaluated with the “Perceived COVID-19 Threat Form (PCTF)”, “Suicide-Ideation Scale (SIS)”, “Hospital
Anxiety and Depression Scale (HADS)”, “The Ability to Cope with Trauma (PACT)”, and “Psychological General Well-Being Index
(PGWB)” scales. BASDAI was used in patients with AS, and DAS28 was used in patients with RA to assess disease severity.
Results: Compared to healthy individuals, patients with RA and AS had lower PGWB scores and higher HADS depression and anxiety
subscale scores. Almost all psychometric assessment test scores were worse in AS patients with high-disease activity compared to those
in low-disease activity. PACT scores were higher in patients with moderate RA compared to patients with mild RA (p = 0.006). While a
positive correlation was identified between BASDAI and most of the psychometric assessment test scores (r = 0 .36 for PCTF, r = 0.53 for
depressive scores, r = 0.54 for anxiety scores, r = 0.57 for suicidal ideation), DAS28 scores were found to be associated only with PACT
total and PACT perceived forward-focused subscale scores (r = –.26 and r = .33, respectively).
Conclusion: Psychologically, AS and RA patients were found to be worse off compared to healthy controls. The perceived COVID threat
and psychological status were associated with disease activity in AS, but not RA patients. Patients with chronic illnesses may be more
vulnerable to the psychological effects of the pandemic, which can worsen disease activity.
Key words: COVID-19, ankylosing spondylitis, rheumatoid arthritis, psychological well-being, disease activity, coping ability

1. Introduction
Rheumatoid arthritis (RA) and ankylosing spondylitis
(AS) are the two most common rheumatological diseases
worldwide [1]. It is known that psychiatric symptoms
such as depressive mood and anxiety are more widespread
in patients with rheumatological diseases than healthy
individuals [2–5]. According to data from the United
States of America, the lifetime prevalence of psychiatric
disorders in RA patients was 63.6% [6]. In a long-term
comprehensive longitudinal Swedish cohort study,
psychiatric symptoms/illnesses were reported to be
more common in patients with AS compared to patients
with RA [7]. A significant relationship was reported
between psychiatric syndromes and disease activity

scores such as Bath Ankylosing Spondylitis Disease
Activity Index (BASDAI), Bath Ankylosing Spondylitis
Functional Index (BASFI), pain and fatigue in patients
with AS [8]. Complaints of anxiety and depression are
frequently encountered in these patients [9]. A significant
relationship between the scale Disease Activity Score in
28 Joints (DAS28), as well as other disease activity scores
and psychiatric syndromes such as anxiety and depression
have also been reported in RA [10].
The novel coronavirus 2019 (COVID-19) outbreak,
which started in Wuhan in January 2019 and then
spread worldwide, has been declared a pandemic and its
repercussions are continuing. Data from the COVID-19
outbreak as well as previous pandemics have shown that
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large-scale outbreaks have a wide spectrum of psychosocial
effects. In particular, patients with chronic diseases are
more susceptible to psychosocial stressors, both physically
and psychologically. Symptoms of psychosocial effects such
as intense stress, nervousness, anxiety, fear, complaints of
depression, decreased tolerance, anger, post-traumatic
stress disorder, and psychosomatic complaints are often
observed [11,12,13]. Additionally, individuals may
obtain incorrect information related to chronic diseases
during the pandemic, both through social media and
their relatives and friends. This may cause an increase in
anxiety levels and a decrease in coping strategies to reduce
psychological well-being overall [14].
Complaints such as depression, sleep disorders, loss of
appetite, and fatigue, which are difficult to adapt to and
make it harder to maintain social communication, can
be seen more frequently in patients with chronic diseases
[15]. Interestingly, the risk of COVID-19 was reported
to not be higher in RA and AS patients with no effect on
the clinical course of these diseases during the pandemic
[16,17]. However, patients with rheumatological diseases,
who are prone to psychological disorders, are likely to be
easily psychologically affected by the COVID-19 outbreak.
Recent studies have shown that patients with RA, axial
spondyloarthritis, lupus, and Behçet Disease were severely
affected by the COVID-19 pandemic [18–21].
In the current study, we aimed to determine how the
COVID-19 pandemic psychologically affected patients
with chronic progressive diseases, such as AS and RA and
the effects of these psychological factors on disease activity.
2. Materials and methods
2.1. Participants
Age and gender-matched patients with AS (n=80), RA
(n=80), and healthy volunteers (n=80) were recruited
for the study. The AS and RA groups were comprised of
patients who were followed up at the Necmettin Erbakan
University, Meram Medical Faculty, Department of
Rheumatology. Patients with AS were contacted by
telephone first and related documents were sent to their
smart-phones via online communication applications. We
excluded patients with other co-morbid chronic diseases
from the current study. Similarly, the healthy control
group was reached via online communication applications.
Relatives of patients with no chronic disease who applied
to the internal medicine outpatient clinic were included
in the healthy control group. Data from RA patients were
obtained with face-to-face interviews at the hospital since
blood analysis results were necessary to calculate DAS28
scores. Participants who were under 18 years old, over 70
years old, and with less than 5 years of formal education
were not included in the study. Additionally, the data
of participants who did not complete all psychometric
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assessment scales were excluded from the analysis. The
sample size was calculated by evaluating the effect size as
0.25, α-err as 0.05, and power as 0.90 with G Power 3.1.9.2
[22,23].
2.2. Ethical approval
The Turkish Ministry of Health, General Directorate of
Health Services approved the study protocol (Approval
Date/Number:
29.04.2020/ŞAKİR
GICA-2020-0429-T16_26_23). The local Ethics Committee on human
research also approved the study (IRB Date/Number:
08.05.2020/2020-2485). Prior to the start of the study, all
participants received an informed consent form stating
the details of the research, and participants who consented
to volunteer approved this form. The participants were
accepted to the study after they provided their written
informed consent.
2.3. Data collection tools
Personal Information Form was used to obtain
demographic information about the participants.
Perceived COVID-19 Threat Form (PCTF) was
developed by Kavaklı et al [17]. The form has seven items
and a five-point Likert type scale ranging from never
(score of 1) to always (score of 5). The developers of
this scale stated that the form has a one-factor structure
according to parallel analysis. The form aims to measure
the participants’ perceived COVID-19 threat levels; a
higher total score corresponds to a higher perceived threat
from the COVID-19 pandemic. Kavaklı et al. reported the
Omega reliability score of the scale as .78 [24].
Suicide Ideation Scale (SIS) is a self-reported test
that was developed in 1989 by Levine et al. The SIS is
comprised of 17 questions that are answered in a yes/no
manner, and the total score of the scale varies between 0
and 17. A high score means pronounced suicidal ideation.
Nesrin et al. performed the validity and reliability studies
for the Turkish scale [25].
Hospital Anxiety and Depression Scale (HADS) was
developed by Zigmond and Sinaith to determine risk
groups by evaluating anxiety and depression in a brief
time in people with physical illness. It is a self-reported
scale comprising 17 questions and 2 sub-dimensions. Its
validity and reliability in the Turkish have been conducted
by Aydemir at al [26].
The Perceived Ability to Cope with Trauma scale
(PACT) is a 5-point Likert-type self-reported scale
developed by Bonanno et al. (2011) to test the perception
of coping with trauma in life [27]. The Turkish form of the
scale is comprised of 20 items and has a 2-factor structure.
There are no inverse items on the scale. Cronbach’s alpha
internal consistency coefficient was calculated as 0.79 for
trauma focus, 0.90 for future focus, and 0.79 for the total
scale. Ari et al. reported the validity and reliability of the
scale in Turkish [28].
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Psychological general well-being index score (PGWB)
score is a self-reported test that was developed by Diener
et al. The score is comprised of eight items that define
important elements of human function from positive
relationships to feelings of efficacy and a meaningful life
[29]. The scores range from 8 (I do not agree with all items
absolutely) to 56 (I agree with all items absolutely). A top
score indicates the presence of psychological resources
and powers in the patient. The adaptation of the scale into
Turkish was carried out by Telef et al. [30].
Bath Ankylosing Spondylitis Disease Activity Index
(BASDAI) is used in the clinical evaluation of AS patients
and is comprised of 6 questions. The patient is asked to
answer the questions by considering events during the past
week [31] and scores the first five questions between 0 and
10 with 0 corresponding to “absent” and 10 corresponding
to “very severe”. The BASDAI score is calculated by
summing the average of the scores obtained from the
fifth and sixth questions and the scores obtained from the
first four questions and dividing the latter score by five.
Akkoc et al. reported the validity and reliability study of
the Turkish version of the scale [32].
Disease Activity Score-28 (DAS28) is used to evaluate
the severity of RA by calculating the swollen, sensitive
joint number, “Erythrocyte Sedimentation Rate (ESR)”
and “Visual Analogue Scale (VAS)” data together. In some
studies, “C-Reactive Protein (CRP)” is also used instead of
ESR [33].
2.4. Procedure
After obtaining ethical approval, the data from the study
participants were gathered online to keep social distance
during the COVID-19 pandemic. All participants
received an informed consent form stating the details
about the study and individuals who volunteered to take
part approved this form. Then, a questionnaire booklet
was created with considerations of the order effect. The
data of patients with RA were obtained with face-to-face
interviews since data from blood analysis were needed to
calculate the DAS28 score.
2.5. Statistical analysis
Descriptive variables are reported as mean ± SD, median
(range), n, and percentage. To evaluate whether the
variables had a normal distribution, visual (histogram and
probability graphs) and analytical (Kolmogorov–Smirnov
and Shapiro–Wilk) tests were conducted. The Kruskal–
Wallis test was used for comparison of the suicidal ideation
scale scores between the multiple independent groups. The
level of statistical significance in nonparametric multiple
comparisons was determined with the Bonferroni
correction (p < 0.05 / number of comparisons). Oneway ANOVA was used for statistical evaluation of the
normally distributed numerical data between multiple
independent groups. For one-way ANOVA, homogeneity

was determined with Levene’s statistic test, followed
by a post hoc least significant difference (LSD) test. The
RA patients were divided into two groups: a remission
or mildly active group (DAS28 < 3.2) and a moderate to
high activity group (DAS28 ≥ 3.2) [34]. The AS patients
were grouped into high disease activity score (BASDAI ≥
4) and low-disease activity score (BASDAI < 4) according
to the BASDAI scores [35]. Based on the parametric
distribution of the data, psychometric assessment scales of
remission/mild and moderate RA patients were compared
with Student’s t-test and AS patients at remission or
non-remission were compared with Mann–Whitney U
test. Chi-square test and Fisher’s Exact test were used to
compare categorical variables between the groups. If both
variables fit the normal distribution, the relationship
between the numerical variables was evaluated using
Pearson correlation analysis, and if at least one of the
variables did not fit the normal distribution, the variables
were evaluated using Spearman correlation analysis. For
statistical significance, a total type-1 error level of 5% was
used.
3. Results
Comparative data on sociodemographic characteristics
and clinical features of patients with AS, RA, and the
healthy control group is shown in Table 1. The mean
BASDAI score of patients with AS was found to be 5.3 ±
2.6, and the mean DAS28 score of RA patients was found
to be 3.0 ± 0.9. The age and sex of the patient with AS, RA,
and control groups were statistically similar. The disease
duration in AS patients was 9.0 ± 7.0 years and the same in
RA patients was 7.8 ± 6.9 years (p = 0.567). No significant
difference was found between the groups in terms of the
presence of psychiatric disorders, smoking, pain level,
and regular exercise. The level of education was found to
be lower in the RA patients compared to AS patients and
the control group (p < 0.001). A significant difference in
working status was found between the groups (p = 0.001).
A comparison of psychometric assessment scale scores
of patients with AS, RA and the healthy control group is
shown in Table 2. Compared to the control group, patients
with RA or AS had lower PGWB scores, and higher HADS
depression and anxiety subscale scores (p = 0.024 and p
= 0.044 for RA patients; p = 0.001 and p = 0.044 for AS
patients, respectively). There was no significant difference
in PCTF, SIS, PACT trauma-focused coping scores between
the groups. PACT perceived forward-focused subscale
scores were significantly lower in RA patients compared to
the control group and AS patients.
All psychometric assessment scales were found to be
significantly different between AS patients with highdisease activity score and low-disease activity score except
the PACT forward-focused sub-dimension. A significant
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Table 1. Comparison of sociodemographic characteristics and clinical features of patients with AS, RA, and healthy control group.
Patients with AS
(n = 80)

Patients with RA
(n = 80)

Control
(n = 80)

p value

Age (years) (mean ± SD)

41.5 ± 8.8

44.4 ± 9.0

42.4 ± 10.3

0.140

Gender (M) (n, %)

42 (52.5%)

24 (30%)

33 (41.25%)

0.149

Disease duration (years) (median (min-max))

7.0(1–30)

5(0–37)

BASDAI score (median (min–max))

5.40 (0–10)

DAS28 score

0.158

3.0 ± 0.9

Pain levels (mean ± SD)
Smoking (n, %)

5.4 ± .2.9

5.6 ± 2.8

0.613

29 (36.25%)

18 (22.5%)

17 (21.25%)

High school and below

49 (61.2%)

70 (89.7%)

0 (0%)

College

31 (38.8%)

8 (10.3%)

80 (100%)

Unemployed

29 (36.25%)

47 (58.75%)

3 (3.75%)

Employed

37 (46.25%)

24 (30%)

61 (76.25%)

Temporary incapacity

4 (5%)

3 (3.75%)

9 (11.25%)

Retired

10 (12.5%)

6 (7.5%)

7 (8.75%)

Married

70 (87.5%)

66 (82.5%)

68 (85%)

0.676

Individuals who exercise regularly (n, %)

14 (17.5%)

24 (30%)

18 (22.5%)

0.464

Individuals inmate with people at risk (n, %)c

47 (58.75%)

25 (31.25%)

45 (56.25%)

0.003 ⃰

21 (26.25%)

22 (27.5%)

0.909

Education (n, %) a
Working status (n, %) b

Marital Status (n, %)

Individuals applying to psychiatry at any time in their life (n, %) 34 (42.5%)

Individuals with psychiatric
illness (n, %)

None

48 (60%)

60(75%)

60 (75%)

Depression

5 (6.25%)

6 (7.5%)

5 (6.25%)

Anxiety

13(16.25%)

5 (6.25%)

8 (10%)

After any trauma

4(5%)

2 (2.5%)

4 (5%)

Obsessive–compulsive disorder

1 (1.25%)

0 (0%)

0 (0%)

Miscellaneous

9 (11.25%)

5 (6.25%)

3 (3.75%)

0.858
<0.001 ⃰
0.001 ⃰

0.975

⃰ p < 0.05, One way ANOVA, Chi-Square and Mann–Whitney U tests were performed. AS: Ankylosing Spondylitis, RA: Rheumatoid
Arthritis. M: Male, BASDAI: Bath Ankylosing Spondylitis Disease Activity Index, DAS28: Disease Activity Score-28.
a
In post hoc analysis of education level between 3 independent group p < 0.001 for each analysis.
b
p < 0.001, when healthy and patients with Ankylosing Spondylitis group were compared; p<0.001, when healthy and patients with
Rheumatoid Arthritis group were compared; p=0.020, when patients with Ankylosing Spondylitis and Rheumatoid Arthritis group were
compared.
c
p = 0.749, when healthy and patients with Ankylosing Spondylitis group were compared; p = 0.002, when healthy and patients with
Rheumatoid Arthritis group were compared; p = 0.001, when patients with Ankylosing Spondylitis and Rheumatoid Arthritis group
were compared.

difference was identified only in the PACT total and
PACT forward-focused sub-dimension scores between
RA patients with mildly active or in remission versus RA
patients with moderate to high active. The comparative
psychometric assessment scale scores of AS and RA
patients according to disease severity are shown in Table 3.
Correlation analyses indicated the presence of a
significant relationship between the BASDAI total score
and scores of most of the psychometric assessment scales
used. The DAS28 scores were found to be significantly
associated only with PACT total and PACT perceived
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forward-focused subscales scores. Correlation analyses
between the BASDAI/DAS28 and psychometric assessment
scales are shown in Table 4. Patients with AS showed a
negative correlation between PCTF scores and PGWB
scores (r = –0.41, p < 0.001) and a positive correlation
between PCTF and SIS, HADS-depression subscale, and
HADS-anxiety subscale (r = 0.40, p < 0.001; r = 0.36, p
= 0.001; r = 0.39, p < 0.001, respectively). However, no
correlation was found between PCTF and PGWB scores
in patients with RA. Nevertheless, similar to patients
with AS, a positive correlation was found between PCTF
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Table 2. Comparison of psychometric assessment scale results of the patients with AS and RA, and control groups.
Control
(n=80)

Patients with AS
(n=80)

Patients with
RA (n=80)

p1

p2

p3

p4

PCTF(mean ± SD)

19.4 ± 5.6

20.5 ± 7.1

19.2 ± 6.5

0.429

0.284

0.908

0.242

PGWB(mean ± SD)

45.7 ± 6.9

42.6 ± 10.0

42.1 ± 10.1

0.024 ⃰

0.024 ⃰

0.014 ⃰

0.819

SIS(median [min-max])

1 (0–11)

2 (0–14)

2 (0–15)

0.215

0.141

0.118

0.881

PACT(mean ± SD)

100.7 ± 14.4

96.5 ± 16.9

92.5 ± 17.5

0.008 ⃰

0.105

0.002 ⃰

0.131

PACT trauma-focused coping(mean ± SD)

63.8 ± 13.1

60.7 ± 14.5

59.7 ± 14.7

0.160

0.168

0.067

0.636

PACT perceived forward-focused(mean ± SD)

36.8 ± 7.1

35.7 ± 8.9

32.9 ± 10.5

0.020 ⃰

0.439

0.007 ⃰

0.050 ⃰

HADS depression (mean ± SD)

5.0 ± 3.7

7.1 ± 4.7

7.2 ± 4

0.001 ⃰

0.002 ⃰

0.001 ⃰

0.873

HADS Anxiety (mean ± SD)

6.1 ± 3.7

7.5 ± 4.4

7.8 ± 5.2

0.044 ⃰

0.019 ⃰

0.054

0.679

⃰ p < 0.05, One way ANOVA and Kruskal–Wallis test were performed. For One-Way ANOVA test, homogeneity was determined with
Levene Statistic test and LSD test was applied in post-hoc analysis.
p1 p value of One way ANOVA or Kruskal–Wallis Test.
p2 Healthy controls vs. patients with Ankylosing Spondylitis.
p3 Healthy controls vs. patients with Rheumatoid Arthritis.
p4 patients with Ankylosing Spondylitis vs. patients with Rheumatoid Arthritis.
Abbreviations: AS: Ankylosing spondylitis, RA: Rheumatoid Arthritis, PCTF: perceived COVID-19 threat form, PGWB: psychological
general well-being index, SIS: suicide ideation scale, PACT: the perceived ability to cope with trauma scale, HADS: hospital anxiety and
depression scale.
Table 3: Comparison of psychometric assessment scores of patients with AS and RA according to disease activity scores.
Ankylosing Spondylitis

Rheumatoid arthritis

Low-ASDAS
Group (n=25)

High-ASDAS
Group (n=55)

p

Remitted or
Mildly Active
Group (n=45)

Moderate or High
p
Active Group (n=34)

PCTF

17 (7–35)

21 (7–35)

0.017 ⃰

18.6 ± 6.9

20.2 ± 6.08

0.300

PGWB

48 (8–56)

43 (17–56)

0.031 ⃰

42.8 ± 9.8

41.1 ± 10.5

0.470

SIS

1 (0–6)

2 (0–14)

0.007 ⃰

2 (0–12)

2 (0–15)

0.385

PACT

104 (5–133)

96 (48–140)

0.030 ⃰

87.9 ± 18.1

98.8 ± 14.8

0.006 ⃰

PACT trauma-focused coping

71 (30–84)

59 (24–84)

0.005 ⃰

57.2 ± 16.7

63.0 ± 11.0

0.091

PACT perceived forward-focused

34 (11–49)

36 (16–56)

0.259

30.7 ± 10.2

35.8 ± 10.3

0.035 ⃰

HADS depression

3 (0–17)

8 (1–18)

<0.001 ⃰

6.6 ± 4.0

8.05 ± 3.9

0.135

HADS Anxiety

4 (0–17)

8 (1–21)

<0.001 ⃰

6.8 ± 4.4

8.4 ± 4.3

0.119

⃰ p<0.05, Student T and Mann–Whitney U tests were performed.
Abbreviations: ASDAS: Ankylosing Spondylitis Disease Activity Score, PCTF: perceived COVID-19 threat form, PGWB: psychological
general well-being index, SIS: suicide ideation scale, PACT: the perceived ability to cope with trauma scale, HADS: hospital anxiety and
depression scale.

and SIS, HADS-depression subscale, and HADS-anxiety
subscale (r = 0.34, p = 0.003; r = 0.23, p = 0.005; r = 0.48, p
< 0.001, respectively) in patients with RA.
4. Discussion
A pandemic that has spread to large masses worldwide
and has caused nearly 2 million deaths will inevitably have

a psychological impact on many individuals, including
patients with chronic diseases such as RA and AS. In the
present study, we investigated the effect of the pandemic
on the psychological status and relationship of the latter
with disease activities in patients with RA and AS. When
compared to healthy controls, we found that patients with
RA as well as AS had low levels of well-being and high
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Table 4. Correlation analysis results between BASDAI / DAS28 scores and psychometric assessment scale
scores.
BASDAI

DAS28

r

p

r

p

PCTF

0.36

0.002

0.03

0.773

PGWB

–0.20

0.088

–0.20

0.078

SIS

0.57

<0.001

0.21

0.063

PACT

–0.15

0.362

–0.26

0.026

PACT trauma-focused coping

–0.26

0.027

0.05

0.655

PACT perceived forward-focused

0.14

0.203

0.33

0.003

HADS depression

0.53

<0.001

0.17

0.144

HADS Anxiety

0.54

<0.001

0.19

0.108

Pearson and spearman (rho) correlation tests were performed.
Abbreviations: BASDAI: Bath Ankylosing Spondylitis Disease Activity Index, PCTF: perceived
COVID-19 threat form, PGWB: psychological general well-being index, COVID-19: novel coronavirus
2019, SIS: suicide ideation scale, PACT: the perceived ability to cope with trauma scale, HADS: hospital
anxiety and depression scale.

levels of depression; patients with RA had low ability to
cope with trauma, while patients with AS had high anxiety
levels. A statistically significant relationship was identified
between disease activity and ability to cope with trauma,
suicidal ideation, depression, and anxiety levels in patients
with AS. AS patients with high disease-activity differ from
AS patients with low-disease activity in all psychometric
areas. In patients with RA, a significant relationship was
identified only between disease activity and the ability
to cope with trauma. The ability to cope with trauma of
patients with moderate to high active RA was higher than
patients with remitted or mildly active RA. We found a
positive correlation between perceived COVID-19 threat
and suicidal ideations, level of depression, and anxiety in
both RA and AS patients. However, a strong correlation
was identified between perceived COVID-19 threat and
psychological well-being in patients with AS, but not in
patients with RA.
Psychiatric disorders such as anxiety, depression,
and stress can often be seen in patients with AS and RA
[36,37] and can significantly reduce their quality of life by
negatively affecting their day to day living [1]. However,
psychiatric symptoms may differ in patients suffering
from these diseases, and the prevalence of psychiatric
symptoms may vary. Sundquist et al. reported that patients
with AS had a higher prevalence of psychiatric symptoms
compared to patients with RA [7]. In a German study, the
frequency of depressive symptoms in patients with axial
spondyloarthritis was found to be similar to patients with
RA [38]. The HADS anxiety and depression scale scores
of both RA and AS patients were reported to be higher
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than healthy controls [9,39]. The psychological well-being
of patients with RA was found to be lower than healthy
controls [40]. To our knowledge, ours is the first study
evaluating the psychological well-being of AS patients
using the PGWB score.
Many patients with rheumatological diseases are likely
to be psychologically affected by the ongoing COVID-19
pandemic. Mancuso et al. reported that the psychiatric
complaints of patients with rheumatological diseases (a
total of 112 patients with Systemic Lupus Erythematosus
(SLE), RA, and Spondyloarthritis) increased significantly
during the pandemic [18]. On the other hand, Kucuk
et al. found that patients with Behçet Disease were
psychologically affected by the pandemic, and their PGWB
scores were low compared to healthy controls, while the
HADS anxiety and depression scores were significantly
higher [19]. Tee et al. detected moderate levels of anxiety,
depression, and stress in patients with RA during the
pandemic [20] but reported that patients with SLE were
affected more by the pandemic than patients with RA [20].
Similarly, Picchianti Diamanti et al. found that patients
suffering from rheumatological diseases such as RA and
AS experienced severe anxiety during the pandemic [21].
Interestingly, Seyahi et al. reported that patients with a
rheumatologic disease had lower anxiety and depression
levels than hospital workers in a large study involving
hospital and academic staff [41]. Previous studies have
already shown that healthcare workers experience a high
degree of anxiety and fear [42,43]. In contrast to the study
by Picchianti Diamanti et al. [21], the current study found
that levels of perceived COVID threat between AS and
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RA patients and healthy controls were similar. These data
suggest that the healthy individuals who participated as
controls in the study also perceived a similar level of threat
of the COVID-19 pandemic as the patients. In our study,
the general psychological well-being of patients with AS
and RA was worse with higher complaints of anxiety and
depression compared to healthy controls. Additionally,
a correlation between perceived COVID threat and the
suicidal ideation, level of depression, and anxiety were
identified in patients with AS and RA suggesting that
these patients were severely affected by the COVID-19
pandemic. In fact, the association of a perceived threat with
distress and lower levels of well-being has been reported
in previous studies conducted on healthy individuals [44].
Similarly, in population studies with large sample sizes,
COVID-19 has been reported to increase the frequency of
the presence of anxiety and depressive symptoms [45].
Whether the follow-up, treatment, and disease activity
of rheumatological diseases changed during the pandemic
has been the subject of many studies [46,47]. Lopez et al.
investigated whether the disease activity scores of patients
with RA and axial spondyloarthritis changed during the
pandemic period and observed that 37.4% of the patients
showed worsening of disease activity [46]. On the other
hand, Ciurea et al. found that disease activity of patients
with neither RA nor AS increased significantly during
the COVID-19 pandemic [47]. The current study did
not evaluate whether the disease activity of patients was
affected by the pandemic directly. Rather, we found that
AS patients with high-disease activity were more affected
by the COVID-19 threat compared to patients with lowdisease activity; their sense of well-being was lower, and
their anxiety and depression scores were higher. At the
same time, a significant relationship was found between
the perceived threat of COVID-19 and disease activity
in patients with AS. Suicidal ideation, ability to cope
with trauma, anxiety and depressive symptoms were
found to be related to disease activity in patients with
AS. However, it was observed that only the ability to
cope with trauma was associated with disease activity in
patients with RA. There were no patients with severe RA
in the current study. The score of coping with trauma was
the only difference identified between moderate RA and
mild RA cases. The fact that the proportion of AS patients
with high-disease activity (68.75%) was higher than the
proportion of AS patients with low-disease activity may
suggest that patients with AS were more affected by the
pandemic compared to patients with RA. Nonetheless, the
lack of patients with severe RA may explain the absence of
a significant relationship between RA disease activity and
psychological parameters. On the other hand, it has been
previously reported that psychological symptoms were

higher in patients with AS compared to patients with RA
[7]. Similarly, in previous studies, it has been reported that
disease activity was associated with psychological status in
patients with AS [9]. Different clinical courses, age of onset,
and gender distributions of the two diseases may result in
differences in psychological factors and symptoms. Levels
of neurotransmitters such as serotonin and noradrenaline,
which play a role in the pathophysiology of depression,
anxiety, and pain, may also differ between patients with
RA and AS [48–51]. Due to these differences, AS and RA
patients may not be affected by the pandemic to the same
extent.
An important outcome of the current study is the
finding of a more pronounced negative correlation between
coping skills and disease activity in patients with RA
compared to patients with AS. A significant relationship
between the perception of pain and inability to cope has
previously been reported in patients with RA [52]. In the
same study, it was emphasized that passive coping skills
were predictors of both depression and pain in patients
with RA, and because RA exacerbations are unpredictable,
individuals with inadequate coping skills interpret the
disease as uncontrollable [52].
In conclusion, the current study showed that patients
with AS and RA displayed a worse psychological status
compared to a healthy control group in response to
the ongoing COVD-19 pandemic. While the perceived
COVID-19 threat was related to most psychometric areas,
both psychometric features and perceived COVID-19
threat were related to disease activity in patients with
AS. In patients with RA, only the perception of coping
with trauma was found to be associated with disease
activity. Patients with AS may be more vulnerable to the
psychological effects of the pandemic, which can affect
disease activity.
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